# Robert Litman, M.D. – FDA Inspection, Feb 20, 2020

Source: https://www.keypedia.com/records/fda_inspections/robert-litman-md/1e74bc9b-1ed3-4969-9cfd-35fc95e70562
Source feed: FDA_Inspections

> FDA inspection 1118290 of Robert Litman, M.D., February 20, 2020. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118290
- Company Name: Robert Litman, M.D.
- Inspection Date: 2020-02-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1264213 - 2025-03-04
- FDA Inspection 819517 - 2013-01-29

Company: https://www.keypedia.com/companies/robert-litman-md/f4a2d872-0435-4df3-9949-2fda169fc6c3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
